PRESS-RELEASE ·Filed Mar 18, 2026
Press release · Earnings
Actionable Insight • Neutral
Traders should await detailed financial disclosures in the upcoming 10-K filing or supplementary materials for meaningful analysis. The lack of data in this release limits immediate trading implications.
Final — all horizons settled through T+60d
FDMT ▲ +2.67% at T+60d
NEUTRAL call +2.67% · α vs SPY -11.67% · entry $8.98 → $9.22
T+1d
-4.12%
call -4.12% · α -2.38%
$8.61
settled 7mo ago
T+5d
+13.36%
call +13.36% · α +15.57%
$10.18
settled 7mo ago
T+20d
+16.82%
call +16.82% · α +9.19%
$10.49
settled 6mo ago
T+60d
+2.67%
call +2.67% · α -11.67%
$9.22
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
4D Molecular Therapeutics reported full-year 2025 financial results and provided operational updates. The press release contains no specific financial figures such as revenue, EPS, or guidance ranges, limiting the ability to assess performance or outlook.
Key Facts
- Company reported full-year 2025 financial results.
- Operational highlights and upcoming milestones were discussed.
- No specific financial metrics (revenue, EPS, guidance) were disclosed in the release.
Financial Impact
Unknown — no quantifiable financial data provided
Risk Factors
- Material financial information may be missing or delayed.
- Potential for market overreaction due to absence of concrete data to anchor expectations.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3258582 |
9 reports for FDMT
100% Hit rate @ T+1 Went positive at some point 4 of 4 best @ T+20▲ +31.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Insider Cluster | $15.00 $14.71 | ▲ +1.93% | ▲ +1.85% | $11.96 (+20.27%) |
Aug 21, 2026 9w ago | Insider Cluster | $15.39 $15.72 | ▲ +2.14% | ▲ +1.82% | $11.96 (−22.29%) |
Jul 20, 2026 14w ago | 8-K | $11.09 $11.38 | ▲ +2.57% | ▲ +1.74% | $11.96 (+7.84%) |
Jul 18, 2026 14w ago | Press Release | $11.09 $11.38 | ▲ +2.57% | ▲ +1.74% | $11.96 (+7.84%) |
Jul 5, 2026 16w ago | Institutional Cluster | $12.72 $12.82 | ▲ +0.79% | ▲ +1.26% | $11.96 (−5.97%) |
Jun 29, 2026 17w ago | 8-K | $12.88 $13.30 | ▲ +3.26% | ▲ +2.48% | $11.96 (−7.14%) |
May 14, 2026 23w ago | EFFECT | $9.81 $9.15 | ▼ −6.73% | ▼ −5.50% | $11.96 (+21.92%) |
May 7, 2026 24w ago | S-3 | $10.14 $10.79 | ▲ +6.41% | ▲ +6.18% | $11.96 (+17.95%) |
Mar 18, 2026 31w ago | Press Release | $8.98 $8.61 | ▼ −4.12% | ▼ −2.38% | $11.96 (+33.18%) |
Showing 9 of 9
US Market Status
Market Closed — Opens Wed (16h 32m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers